• Home
  • Company
    • History
    • Ambition
    • Services
    • Group of companies
    • Partners
  • Quality
    • Our Promise
    • Permissions & Certificates
  • Products
    • Portfolio >
      • Epinephrine Base
      • Epinephrine Bitartrate
      • Clenbuterol HCl
      • Scopolamine Base
      • Scopolamine Hydrobromide
      • Scopolamine Methylbromide
      • ... more Products
    • Portfolio TP USA
  • Sustainability
    • Environmental
    • Social
    • Governance
  • Team
    • Sales & Marketing
    • Logistics
    • Scientific & Regulatory
    • Administration
    • Management
    • TP USA
  • Contact
    • Germany
    • USA
    • Hong Kong
    • Singapore
  • Blog
  • DE/EN
Transo-Pharm.com
  • Home
  • Company
    • History
    • Ambition
    • Services
    • Group of companies
    • Partners
  • Quality
    • Our Promise
    • Permissions & Certificates
  • Products
    • Portfolio >
      • Epinephrine Base
      • Epinephrine Bitartrate
      • Clenbuterol HCl
      • Scopolamine Base
      • Scopolamine Hydrobromide
      • Scopolamine Methylbromide
      • ... more Products
    • Portfolio TP USA
  • Sustainability
    • Environmental
    • Social
    • Governance
  • Team
    • Sales & Marketing
    • Logistics
    • Scientific & Regulatory
    • Administration
    • Management
    • TP USA
  • Contact
    • Germany
    • USA
    • Hong Kong
    • Singapore
  • Blog
  • DE/EN

Transo-Pharm Epinephrine (Adrenaline) Approved in China

5/6/2025

0 Comments

 
We are excited to share that our Epinephrine (Adrenaline) API has received DMF (Drug Master File) approval from the NMPA (National Medical Products Administration) in China. The approval (#Y20190000447) was officially published on the CDE (Center for Drug Evaluation) website on April 16, 2025.
With this important milestone, Transo-Pharm is ready to fully support clients planning to launch formulations containing our Epinephrine API in the Chinese market.
For more information or support, please contact our Product Manager, Jessica Ha, at [email protected].
Picture
0 Comments

Providing regulatory documents - request form

3/22/2022

1 Comment

 
Part of our Transo-Pharm service in regulatory affairs is to send necessary documents, such as Drug Master Files, Letter of Access / Authorisation and Declaration of Accesses to CEPs to our customers for their regulatory activities.

​The scope is wide with many special wishes and requirements.
Picture

Read More
1 Comment

Transo-Pharm's succesful co-operation with the USP

1/13/2021

0 Comments

 
With the next-to-last USP 42.2 update, a lot of changes were implemented in the Epinephrine USP monograph with the help of Transo-Pharm. Due to the high enantiomeric purity and the state-of-art HPLC test method, Transo-Pharm was in the best position to effectively support the US FDA.
Picture
epinephrine_base_usp.pdf
File Size: 222 kb
File Type: pdf
Download File

0 Comments

Scientific and Regulatory Support at Transo-Pharm

9/23/2020

0 Comments

 
Our scientific team in Germany (6 members including 3 PhDs - backgrounds in chemistry and pharmacy) has over 50 combined years of work experience.
sra_support_tph.pdf
File Size: 126 kb
File Type: pdf
Download File

Picture
0 Comments

Enantiomeric purity – and the associated advantages of Transo-Pharm’s Epinephrine (synonym = Adrenaline)

5/29/2020

0 Comments

 
Enantiomeric purity in chiral molecules – such as Transo-Pharm’ s Epinephrine Base and Bitartrate – have been in the focus of the health authorities for some time now. Transo-Pharm is well prepared to fully satisfy the more stringent requirements with their state-of-the-art stereo-selective manufacturing process. Transo-Pharm is therefore in the position to achieve an Enantiomeric Excess (ee) of 99% in commercial production for several years now. This is a significant contribution to ensure patient safety.

Please find the full article below. Learn more about the science behind this topic.

Read More
0 Comments

Adrenaline base and tartrate – DMF filing in Brazil

5/6/2020

0 Comments

 
During CPhI 2019 in Frankfurt the Brazilian Health Authority, ANVISA invited stakeholders to their lecture and dialogues “APIs and the New Brazilian Regulation”.
 
The below brief summary outlines the new guidance for filling DMFs (DIFA) in Brazil as well as some API GMP issues. In respect to our Adrenaline base and tartrate we filed the CEP corresponding DMFs following the below option b) plus notification of availability of a CEP.

Picture

Read More
0 Comments

Nitrosamine risk evaluation

2/28/2020

0 Comments

 
No Nitrosamine risk with Epinephrine Base / Bitartrate from Transo-Pharm as our recently conducted risk evaluation report reveals.

The conclusion is now available on request.
0 Comments

Adrenaline CEP's: out of range country acceptance

1/15/2020

0 Comments

 
CEPs are recognised by the European Pharmacopoeia member states and by a number of other countries. A full current list of the Ph. Eur. members is available on EDQM website. Based on Transo-Pharm's experience we easily penetrated those markets utilizing our CEPs for Adrenaline Base as well as Tartrate.

But what about countries outside EU or Ph. Eur. member states? 

Meanwhile we adjusted our filing strategy in this matter and our Adrenaline CEPs have been submitted to several “out of range” countries. 


Picture

Read More
0 Comments

    Categories

    All
    Alkaloids
    Cannabinoids
    Carbon Footprint
    CBD
    CEP
    Chief Christmas Officers
    COVID 19
    CPhI
    DCAT
    Digoxin
    EDQM
    Emissions
    Environmental
    Epinephrine
    Estriol
    GMP
    Good Bye!
    Green
    Hapila
    Little Guy
    Logistics
    Nonivamide
    Partner
    Partnership
    Phyto
    Regulation
    Regulatory
    Safety
    Season Greetings
    Supply Chain
    Transo Pharm US
    Transo-Pharm US


    Archives

    February 2025
    December 2024
    October 2024
    September 2024
    August 2024
    July 2024
    June 2024
    March 2024
    February 2024
    December 2023
    October 2023
    June 2023
    March 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    June 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    June 2020
    May 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019

    RSS Feed

Services

Sourcing
Sales
Development

Products

Portfolio
​US Portfolio

Company

History
Ambition
​Services
Group
Partners
​
Quality Policy 
​Certificates

Team

Sales & Marketing
Logistics
Scientific & Regulatory
Administration
​Management
​TP USA

Contact

Germany
Hong Kong
Singapore
USA
Sitemap
Support
German Site
Imprint / Legal
Data Privacy
Sustainability
© COPYRIGHT 2020
​ALL RIGHTS RESERVED.

Picture
Picture
  • Home
  • Company
    • History
    • Ambition
    • Services
    • Group of companies
    • Partners
  • Quality
    • Our Promise
    • Permissions & Certificates
  • Products
    • Portfolio >
      • Epinephrine Base
      • Epinephrine Bitartrate
      • Clenbuterol HCl
      • Scopolamine Base
      • Scopolamine Hydrobromide
      • Scopolamine Methylbromide
      • ... more Products
    • Portfolio TP USA
  • Sustainability
    • Environmental
    • Social
    • Governance
  • Team
    • Sales & Marketing
    • Logistics
    • Scientific & Regulatory
    • Administration
    • Management
    • TP USA
  • Contact
    • Germany
    • USA
    • Hong Kong
    • Singapore
  • Blog
  • DE/EN